4 employees
Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.
2021
$2.4M
from 4 investors over 4 rounds
eGlint, Inc. raised $2.4M on November 12, 2021
Investors: Breakthrough Energy Ventures, Emerald BioVentures, Ulu Ventures and SeedFolio